Markets lower amid WHO warning - Tuesday Review, March 2

Markets lower amid WHO warning - Tuesday Review, March 2

The number of COVID-19 infections rose for the first time in nearly two months during the past week, causing the stocks to put a stop to Monday’s momentum

The US

WHO’s warning that it is too early for countries to rely only on vaccination programs and abandon other measures caused Wall Street to close in the red. USA30 traded 0.46% lower, and USA500 fell 0.78%. TECH100 went down 1.69%.

Crude oil lost 0.9% to $60.11 per barrel.

Gold fell 0.2% to $1,720.25 per ounce.

Asia and Australia

HongKong45 slid 1.08% after the changes to the Hang Seng Index were revealed.

Japan225 was down 0.71%.

Down under, Australia200 edged up 0.19% as the country’s Reserve Bank was due to hand down its interest rate decision.

Europe

Markets traded lower as investors were worried about the rising number of COVID-19 infections. Germany30 lost 0.5%, France40 fell 0.1%. UK100 dropped 0.2%.

Brent oil traded 1% lower at $63.08 a barrel.

EUR/USD traded at 1.2020 after it lost 0.2%.

Sources: reuters.com, investing.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.